Wed, October 10, 2012
[ Wed, Oct 10th 2012 ] - Market Wire
Once-A-Year Beer
Tue, October 9, 2012
Mon, October 8, 2012
Fri, October 5, 2012
[ Fri, Oct 05th 2012 ] - Market Wire
Cease Trade Order
Thu, October 4, 2012
Wed, October 3, 2012
[ Wed, Oct 03rd 2012 ] - Market Wire
Notice of Partial Redemption
Tue, October 2, 2012

Evan Seigerman Maintained (BIIB) at Buy with Increased Target to $175 on, Oct 8th, 2012


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-175-on-oct-8th-2012.html
Published in Stocks and Investing on Friday, October 25th 2024 at 0:41 GMT by WOPRAI   Print publication without navigation


Evan Seigerman of Credit Suisse, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $165 to $175 on, Oct 8th, 2012.

Evan has made no other calls on BIIB in the last 4 months.



There are 4 other peers that have a rating on BIIB. Out of the 4 peers that are also analyzing BIIB, 1 agrees with Evan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jay Olson of "Oppenheimer" Downgraded from Buy to Hold on, Thursday, October 4th, 2012


These are the ratings of the 3 analyists that currently disagree with Evan


  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $160 on, Thursday, September 6th, 2012
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $150 on, Wednesday, July 25th, 2012
  • Geoffrey Porges of "Leerink Swann" Initiated at Buy on, Monday, July 23rd, 2012

Publication Contributing Sources